Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nita Chainani Wu
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients presenting to the UCSF oral medicine clinic diagnosed with either the atrophic or the erosive form of oral lichen planus
Study subjects must have a symptom score between 3 to 8 at the time of entry into the study. (Range of scale: zero to ten with zero being no symptoms and ten being the worst imaginable symptoms.
Study subjects will have discontinued systemic and/or topical steroids and/or curcuminoids for at least 2 weeks before entry into the study.
You may not be if
Pregnancy, lactation or unwillingness to use an effective method of contraception. An attempt will be made to ascertain the date of the last menstrual period among eligible pre-menopausal women. If pregnancy cannot be ruled out, a pregnancy test will be provided to the women before enrollment into the study. - Patients younger than 21 years of age.
Patients who cannot return for a follow-up visit at two weeks after enrollment.
Patients who have a medical contraindication to discontinuation of systemic steroids eg. those on long term corticosteroid therapy. - Patients with a history of gastro-esophageal reflux disease, gastric / duodenal ulcers, or gallstones.
Patients with elevated liver enzymes;
Patients on anticoagulants or antiplatelet medications.
Patients undergoing orthodontic treatment.
Patients who don't read, speak or understand English.
Clareo Health | A Clinical Study of Curcuminoids in the Treatment of Oral Lichen Planus
